| Optical biosensors in drug discovery MA Cooper Nature reviews Drug discovery 1 (7), 515-528, 2002 | 1197 | 2002 |
| A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases RC Coll, AAB Robertson, JJ Chae, SC Higgins, R Muņoz-Planillo, ... Nature medicine 21 (3), 248-255, 2015 | 1183 | 2015 |
| Label-free screening of bio-molecular interactions MA Cooper Analytical and bioanalytical chemistry 377 (5), 834-842, 2003 | 553 | 2003 |
| Fix the antibiotics pipeline MA Cooper, D Shlaes Nature 472 (7341), 32-32, 2011 | 477 | 2011 |
| Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice JJ Fuster, S MacLauchlan, MA Zuriaga, MN Polackal, AC Ostriker, ... Science 355 (6327), 842-847, 2017 | 470 | 2017 |
| A survey of the 2001 to 2005 quartz crystal microbalance biosensor literature: applications of acoustic physics to the analysis of biomolecular interactions MA Cooper, VT Singleton Journal of Molecular Recognition: An Interdisciplinary Journal 20 (3), 154-184, 2007 | 437 | 2007 |
| Antibiotics in the clinical pipeline in 2013 MS Butler, MA Blaskovich, MA Cooper The Journal of antibiotics 66 (10), 571-591, 2013 | 433 | 2013 |
| Natural product and natural product derived drugs in clinical trials MS Butler, AAB Robertson, MA Cooper Natural product reports 31 (11), 1612-1661, 2014 | 430 | 2014 |
| PtdIns (3) P regulates the neutrophil oxidase complex by binding to the PX domain of p40 phox CD Ellson, S Gobert-Gosse, KE Anderson, K Davidson, ... Nature cell biology 3 (7), 679-682, 2001 | 427 | 2001 |
| Biomarkers in chronic kidney disease: a review RG Fassett, SK Venuthurupalli, GC Gobe, JS Coombes, MA Cooper, ... Kidney international 80 (8), 806-821, 2011 | 420 | 2011 |
| Emerging pathogenic links between microbiota and the gut–lung axis KF Budden, SL Gellatly, DLA Wood, MA Cooper, M Morrison, ... Nature Reviews Microbiology 15 (1), 55-63, 2017 | 417 | 2017 |
| Genome-wide survey of protein kinases required for cell cycle progression M Bettencourt-Dias, R Giet, R Sinka, A Mazumdar, WG Lock, F Balloux, ... Nature 432 (7020), 980-987, 2004 | 371 | 2004 |
| Human monocytes engage an alternative inflammasome pathway MM Gaidt, TS Ebert, D Chauhan, T Schmidt, JL Schmid-Burgk, F Rapino, ... Immunity 44 (4), 833-846, 2016 | 353 | 2016 |
| Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices S Krugmann, KE Anderson, SH Ridley, N Risso, A McGregor, J Coadwell, ... Molecular cell 9 (1), 95-108, 2002 | 318 | 2002 |
| Antibiotics in the clinical pipeline in 2011 MS Butler, MA Cooper The Journal of antibiotics 64 (6), 413-425, 2011 | 305 | 2011 |
| NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice AR Mridha, A Wree, AAB Robertson, MM Yeh, CD Johnson, ... Journal of hepatology 66 (5), 1037-1046, 2017 | 303 | 2017 |
| Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals KL Ormerod, DLA Wood, N Lachner, SL Gellatly, JN Daly, JD Parsons, ... Microbiome 4 (1), 1-17, 2016 | 290 | 2016 |
| Aminoglycoside antibiotics in the 21st century B Becker, MA Cooper ACS chemical biology 8 (1), 105-115, 2013 | 263 | 2013 |
| Advances in membrane receptor screening and analysis MA Cooper Journal of Molecular Recognition 17 (4), 286-315, 2004 | 263 | 2004 |
| Antibiotics in the clinical pipeline at the end of 2015 MS Butler, MAT Blaskovich, MA Cooper The Journal of antibiotics 70 (1), 3-24, 2017 | 262 | 2017 |
Mark BlaskovichGroup Leader, Institute for Molecular Bioscience, The University of QueenslandVerified email at uq.edu.au
